175 related articles for article (PubMed ID: 30859087)
21. High motility group box 1 (HMGB1) protein and its receptor for advanced glycation end products (RAGE) expression in chronic rhinosinusitis without nasal polyps.
Dzaman K; Zagor M; Molinska-Glura M; Krzeski A
Folia Histochem Cytobiol; 2015; 53(1):70-8. PubMed ID: 25772690
[TBL] [Abstract][Full Text] [Related]
22. High Mobility Group Box-1 Drives Fibrosis Progression Signaling via the Receptor for Advanced Glycation End Products in Mice.
Ge X; Arriazu E; Magdaleno F; Antoine DJ; Dela Cruz R; Theise N; Nieto N
Hepatology; 2018 Dec; 68(6):2380-2404. PubMed ID: 29774570
[TBL] [Abstract][Full Text] [Related]
23. High-Mobility Group Box 1 (HMGB1) Induces Migration of Endothelial Progenitor Cell via Receptor for Advanced Glycation End-Products (RAGE)-Dependent PI3K/Akt/eNOS Signaling Pathway.
Zhang Y; You B; Liu X; Chen J; Peng Y; Yuan Z
Med Sci Monit; 2019 Aug; 25():6462-6473. PubMed ID: 31461437
[TBL] [Abstract][Full Text] [Related]
24. HMGB1/RAGE induces IL-17 expression to exaggerate inflammation in peripheral blood cells of hepatitis B patients.
Jhun J; Lee S; Kim H; Her YM; Byun JK; Kim EK; Lee SK; Cho ML; Choi JY
J Transl Med; 2015 Sep; 13():310. PubMed ID: 26391982
[TBL] [Abstract][Full Text] [Related]
25. HMGB1 regulates T helper 2 and T helper17 cell differentiation both directly and indirectly in asthmatic mice.
Li R; Wang J; Zhu F; Li R; Liu B; Xu W; He G; Cao H; Wang Y; Yang J
Mol Immunol; 2018 May; 97():45-55. PubMed ID: 29567318
[TBL] [Abstract][Full Text] [Related]
26. [Protective effect of Shenfu injection on the endothelium of severe sepsis by inhibiting CD11b
Xing Y; Cheng D; Shi C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jun; 32(6):696-701. PubMed ID: 32684215
[TBL] [Abstract][Full Text] [Related]
27. sRAGE alleviates neutrophilic asthma by blocking HMGB1/RAGE signalling in airway dendritic cells.
Zhang F; Su X; Huang G; Xin XF; Cao EH; Shi Y; Song Y
Sci Rep; 2017 Oct; 7(1):14268. PubMed ID: 29079726
[TBL] [Abstract][Full Text] [Related]
28. HMGB1 binds to activated platelets via the receptor for advanced glycation end products and is present in platelet rich human coronary artery thrombi.
Ahrens I; Chen YC; Topcic D; Bode M; Haenel D; Hagemeyer CE; Seeba H; Duerschmied D; Bassler N; Jandeleit-Dahm KA; Sweet MJ; Agrotis A; Bobik A; Peter K
Thromb Haemost; 2015 Nov; 114(5):994-1003. PubMed ID: 26202300
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of receptor for advanced glycation end products and high-mobility group box 1 in human dental pulp inflammation.
Tancharoen S; Tengrungsun T; Suddhasthira T; Kikuchi K; Vechvongvan N; Tokuda M; Maruyama I
Mediators Inflamm; 2014; 2014():754069. PubMed ID: 25114379
[TBL] [Abstract][Full Text] [Related]
30. The myocardial infarct-exacerbating effect of cell-free DNA is mediated by the high-mobility group box 1-receptor for advanced glycation end products-Toll-like receptor 9 pathway.
Tian Y; Charles EJ; Yan Z; Wu D; French BA; Kron IL; Yang Z
J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2256-2269.e3. PubMed ID: 30401529
[TBL] [Abstract][Full Text] [Related]
31. [Effect of high mobility group box protein 1 on the Kupffer cells of rats with severe burn and the role of receptor for advanced glycation end products in the process].
Sun L; Chen XL; Guo F; Wang F; Liu S; Liang X; Wang RS; Wang YJ; Sun YX
Zhonghua Shao Shang Za Zhi; 2013 Apr; 29(2):158-61. PubMed ID: 23985205
[TBL] [Abstract][Full Text] [Related]
32. Co-expression of RAGE and HMGB1 is associated with cancer progression and poor patient outcome of prostate cancer.
Zhao CB; Bao JM; Lu YJ; Zhao T; Zhou XH; Zheng DY; Zhao SC
Am J Cancer Res; 2014; 4(4):369-77. PubMed ID: 25057439
[TBL] [Abstract][Full Text] [Related]
33. HMGB1-induced autophagy: a new pathway to maintain Treg function during chronic hepatitis B virus infection.
Cheng LS; Li J; Liu Y; Wang FP; Wang SQ; She WM; Wu SD; Qi XL; Zhou YP; Jiang W
Clin Sci (Lond); 2017 Mar; 131(5):381-394. PubMed ID: 28082516
[TBL] [Abstract][Full Text] [Related]
34. Anti-high-mobility group box-1 (HMGB1) mediates the apoptosis of alveolar epithelial cells (AEC) by receptor of advanced glycation end-products (RAGE)/c-Jun N-terminal kinase (JNK) pathway in the rats of crush injuries.
Zhang BF; Song W; Wang J; Wen PF; Zhang YM
J Orthop Surg Res; 2022 Jan; 17(1):20. PubMed ID: 35033142
[TBL] [Abstract][Full Text] [Related]
35. HMGB1 and RAGE in skeletal muscle inflammation: Implications for protein accumulation in inclusion body myositis.
Muth IE; Zschüntzsch J; Kleinschnitz K; Wrede A; Gerhardt E; Balcarek P; Schreiber-Katz O; Zierz S; Dalakas MC; Voll RE; Schmidt J
Exp Neurol; 2015 Sep; 271():189-97. PubMed ID: 26048613
[TBL] [Abstract][Full Text] [Related]
36. Potential role of IL-17-producing CD4/CD8 double negative αβ T cells in psoriatic skin inflammation in a TPA-induced STAT3C transgenic mouse model.
Ueyama A; Imura C; Fusamae Y; Tsujii K; Furue Y; Aoki M; Suzuki M; Okuda T; Oshima I; Yasui K; Shichijo M; Yamamoto M
J Dermatol Sci; 2017 Jan; 85(1):27-35. PubMed ID: 27810232
[TBL] [Abstract][Full Text] [Related]
37. High-mobility group box 1 inhibits HCO(3)(-) absorption in medullary thick ascending limb through a basolateral receptor for advanced glycation end products pathway.
Good DW; George T; Watts BA
Am J Physiol Renal Physiol; 2015 Oct; 309(8):F720-30. PubMed ID: 26180239
[TBL] [Abstract][Full Text] [Related]
38. Lipoxin A4 and its analog suppress inflammation by modulating HMGB1 translocation and expression in psoriasis.
Liu X; Wang X; Duan X; Poorun D; Xu J; Zhang S; Gan L; He M; Zhu K; Ming Z; Hu F; Chen H
Sci Rep; 2017 Aug; 7(1):7100. PubMed ID: 28769106
[TBL] [Abstract][Full Text] [Related]
39. Up-regulation of HMGB1 and TLR4 in skin lesions of lichen planus.
de Carvalho GC; Hirata FYA; Domingues R; Figueiredo CA; Zaniboni MC; Pereira NV; Sotto MN; Aoki V; da Silva Duarte AJ; Sato MN
Arch Dermatol Res; 2018 Aug; 310(6):523-528. PubMed ID: 29728859
[TBL] [Abstract][Full Text] [Related]
40. Trimebutine attenuates high mobility group box 1-receptor for advanced glycation end-products inflammatory signaling pathways.
Nakajima S; Ogawa N; Yokoue N; Tachibana H; Tamada K; Okazawa M; Sato A; Oyama T; Abe H; Kamiya T; Yoshimori A; Yoshizawa K; Inoue S; Yokomizo T; Uchiumi F; Abe T; Tanuma SI
Biochem Biophys Res Commun; 2020 Dec; 533(4):1155-1161. PubMed ID: 33041002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
